semaglutide didn't work for me patients with #obesity, semaglutide, a glucagon-like peptide-1 receptor agonist, is approved for weight management as a once-weekly subcutaneous injection. In a previous trial, oral at a dose of 50 mg Didn't even notice the change

Gut 2022;71:156-162

That means getting: A high-fiber diet with fruits, vegetables, legumes, and whole grains Plenty of water Stool softeners, such as polyethylene glycol (MiraLAX) or docusate (Colace) Warm sitz baths (10 to 15 minutes, up to 3 times a day) to relax the anal muscles, ease pain, and promote healing 1 You can use the Bristol Stool Chart to guide your progress

A cryo-EM structure of Ex4-D-Ala bound to GLP-1R/Gs To investigate the receptor-bound conformation of the potent exendin-4 analogue containing D-Ala in place of Gly4 (referred to below as Ex4-D-Ala), we undertook cryo-EM studies of the complex formed by this agonist with the GLP-1R

Japan With Love was established in December 2020 with great experiences and understanding of Japanese products

People who took tirzepatide drugs had a much lower incidence

When Appetite Disappears: Recognising Eating-Disorder Risk Because these medications blunt appetite, they can sometimes trigger or worsen restrictive eating patterns in people who are vulnerable